Center for Leading Innovation & Collaboration
  • CLIC Virtual Tour artwork - laptop with documents, video icons etc floating around it

    The CLIC Virtual Tour is designed to give everyone involved with the CTSA Program, regardless of in what capacity, an overview of what CLIC provides and how to make it work for you. Think: a virtual ‘walk-through’ of new website resources, ways to communicate and guidance on how to access. It will be a multipart series, including live question and answer sessions. Videos will be released on the

  • Various images of the exVo platform including the Main Stage, daily schedule board, rooftop networking lounge, and tropical view from inside the venue.
    In early December, over 700 CTSA Program members gathered for the virtual 2021 CTSA Program Annual Meeting: “Intentional Disruption and Innovation: The Future of Translational Science.” This event focused on the CTSA Program hubs’ innovations that were spurred by the COVID pandemic and how to harness intentional disruption to foster similar innovation in the post-COVID world. In line with the
  • The University of Pennsylvania will be conducting a mixed methods study, funded by NCATS through a bioethics supplement to the University of Pennsylvania’s CTSA, to examine institutional approaches to prioritizing COVID-19 trials. The goal of this study is to understand relevant processes and criteria applied during the pandemic, as well as perspectives on potentially extending these approaches to
  • A microscope with DNA strands in the background.

    The Center for Leading Innovation and Collaboration (CLIC), the coordinating center for the NCATS CTSA Program, is hosting this Un-Meeting. This is an unconventional meeting, which lacks the rules and structure of a traditional conference, focuses on bringing together researchers, clinicians, policymakers, public health professionals, healthcare innovators, and opinion leaders to discuss and develop innovative and effective ideas regarding climate change in human health. 
    The link between C2H2 and translational science is not intuitive for all. Working backward from climate-related disease to

  • CLIC

    Over the last five years, CLIC has engaged stakeholders and partners across the consortium to amplify the research of CTSAs and communicate the impact of translational science. We have translated data into action by creating annual bi-directional metric reports, disseminating stories through the Insights to Inspire annual program, and developing actionable and sustainable resources, From Insights

  • graphic showing the SERIE process

    What is the real-world impact of our network? That is a question the Clinical and Translational Science Awards Program has been trying to answer since its inception. Over the past four years, the Center for Leading Innovation and Collaboration has pitched in on that effort, knitting together several tried and trusted evaluation methods to develop a new Stakeholder-Engaged Research Impact

  • City Scape with lines and orbs above locations implying people connecting to a virtual network
    Meeting Theme: Intentional Disruption and Innovation: The Future of Translational Science Objective: To highlight changes and innovations that CTSA Program consortium hubs had to make during the COVID pandemic; describing the creative innovations developed and what they suggest concerning intentionally causing the disruption and spurring innovative solutions in the post-COVID world.
  • Telehealth is an emerging field. Prior to the pandemic, telehealth was shown in several chronic conditions to improve access, reduce hospitalization rates, and have lower costs to the patient than traditional in person visits. These interventions are adaptable and have the potential to impact healthcare in communities which are medically underserved and under-resourced. Telehealth has also been shown to reduce health disparities among African Americans, improve screenings of chronic conditions and improve access to mental health care in rural areas. During the COVID-19 pandemic there has been

  • Looking to encourage members of your hub to get involved on Twitter? Feel free to use and modify this deck, aimed at those who are new to the platform.

  • Background image with buildings, medical supplies and a farm

    May 27, 11:00 AM - 3:00 PM Eastern Time. This NCATS “Rapid-Response” Un-Meeting will encourage discussions to identify activities that can be initiated and sustained in the interpandemic period to include when a significant public health emergency arises in the future, these community based environments can seamlessly participate in joint projects to address the threat. Other potential topics include identifying opportunities to build models of outreach to better include community hospitals for recruitment and enrollment into academic clinical trials, identifying ways to increase participant

  • Journal of Clinical and Translational Science

    In this paper, we address how the COVID-19 pandemic has impacted informed consent for clinical research through examining experiences within Clinical and Translation Science Award (CTSA) institutions. We begin with a brief overview of informed consent and the challenges that existed prior to COVID-19.

  • Journal of Clinical and Translational Science

    Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities.

  • Journal of Clinical and Translational Science

    Rapid development and deployment of diagnostic testing for COVID-19 has been a key component of the public health response to the pandemic. Out of necessity, academic and other clinical laboratories developed laboratory testing innovations for COVID-19 to meet clinical testing demands.

  • Journal of Clinical and Translational Science

    Introduction: In March 2020 academic medical center (AMC) pharmacies were compelled to implement practice changes in response to the COVID-19 pandemic. These changes were described by survey data collected by the Clinical and Translational Science Awards (CTSA) program which were interpreted by a multi-institutional team of AMC pharmacists and physician investigators.

  • Journal of Clinical and Translational Science

    Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team.

  • Journal of Clinical and Translational Science

    Introduction: With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials.

  • Journal of Clinical and Translational Science

    Introduction: The COVID-19 pandemic changed the clinical research landscape in America. The most urgent challenge has been to rapidly review protocols submitted by investigators that were designed to learn more about or intervene in COVID-19. Methods: IRB Offices developed plans to rapidly review protocols related to the COVID-19 pandemic.

  • Journal of Clinical and Translational Science

    Introduction: The Coronavirus Disease 2019 (COVID-19) created major disruptions at academic centers and health care systems globally. Clinical and Translational Science Awards (CTSA) fund hubs supported by the National Center for Advancing Translational Sciences which provide infrastructure and leadership for clinical and translational research at many such institutions.

  • Journal of Clinical and Translational Science

    Biospecimen repositories play a vital role in enabling investigation of biologic mechanisms, identification of disease-related biomarkers, advances in diagnostic assays, recognition of microbial evolution, and characterization of new therapeutic targets for intervention.

  • The 2020 COVID-19 pandemic has had a profound impact on the clinical research enterprises at the 60 Clinical and Translational Science Award (CTSA) Hubs throughout the nation.

  • Journal of Clinical and Translational Science

    The recipients of NIH Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research.

  • Journal of Clinical and Translational Science

    Clinical and Translational Science Award (CTSA) TL1 trainees and KL2 scholars were surveyed to determine the immediate impact of the COVID-19 pandemic on training and career development. The most negative impact was lack of access to research facilities, clinics, and human subjects, plus for KL2 scholars lack of access to team members and need for homeschooling.

  • Journal of clinical and translational science

    Although the science of team science is no longer a new field, the measurement of team science and its standardization remain in relatively early stages of development. To describe the current state of team science assessment, we conducted an integrative review of measures of research collaboration quality and outcomes.

  • Journal of clinical and translational science

    In order to conduct translational science, scientists must combine domain-specific expertise with knowledge on how to identify and cross translational hurdles, and insights on positioning discoveries for the next translational stage.

  • Message Boards
    Message Board

    Welcome to the new Well-Being Integration Working Group Message Board!

    This message board is available to all in the Well-Being Integration Working Group on the CLIC website. Posts and replies are only visible to the Well-Being Integration Working Group.


  • Northwestern Logo
    Northwestern University At Chicago
    The Northwestern University Clinical and Translational Sciences (NUCATS) Institute is hosting Medical University of South Carolina (MUSC) KL2 Scholar, DeAnna Baker Frost MD, PhD on February 2, 2021, 12-1 p.m. CST as a part of the CLIC-CTSA Visiting Scholar Program. Dr. Baker Frost will present on 'The Influence of Hormonal Dysregulation in Autoimmunity.' Objectives: Provide a brief overview of
  • Journal of Clinical and Translational Science

    A primary barrier to translation of clinical research discoveries into care delivery and population health is the lack of sustainable infrastructure bringing researchers, policymakers, practitioners, and communities together to reduce silos in knowledge and action.

  • Virtual Tour Part 2

    The different types of CTSA Program Groups have different objectives as well as different membership requirements. Each CTSA Program hub is allowed to have one voting representative on the Enterprise Committee. This member is appointed by the hub PI and is the primary point of contact for their hub for all matters relating to their specific Enterprise Committee.

  • Journal of Clinical and Translational Science

    Introduction: Addressing rural health disparities has unique challenges which require cross sector collaborations to address social determinants of health and help those in need get connected to care continuum.

  • To elicit participant feedback on the 2019 Lifespan Integration DTF Face-to-Face Meeting